Clinical Trial Update: Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares solifenacin, levofloxacin, and lornoxicam for managing side effects of intravesical BCG therapy in non-muscle-invasive bladder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Levofloxacin (Levofloxacin)
• Lornoxicam (lornoxicam)
• Solifenacin (solifenacin)

Snippet

Sponsor: Mansoura University | Conditions: Non-Muscle-invasive Bladder Cancer (NMIBC), Bacillus Calmette-Guerin (BCG) Cystitis | Phase 4 | Status: UNKNOWN